APA (7th ed.) Citation

Wang, S., Lin, Y., Xiong, X., Wang, L., Guo, Y., Chen, Y., . . . Zhang, H. (2020). Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial. Clinical cancer research, 26(18), 4921-4932. https://doi.org/10.1158/1078-0432.CCR-20-0113

Chicago Style (17th ed.) Citation

Wang, Shuhong, et al. "Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial." Clinical Cancer Research 26, no. 18 (2020): 4921-4932. https://doi.org/10.1158/1078-0432.CCR-20-0113.

MLA (9th ed.) Citation

Wang, Shuhong, et al. "Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial." Clinical Cancer Research, vol. 26, no. 18, 2020, pp. 4921-4932, https://doi.org/10.1158/1078-0432.CCR-20-0113.